Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Study confirms modified bismuth quadruple therapy...
In the face of rising Helicobacter pylori (H. pylori) elimination failure, a new systematic review and meta-analysis offers promising evidence th...
Evaluation of folic acid for H. pylori-associated...
This systematic review and meta-analysis determined folic acid's efficiency and safety in treating chronic atrophic gastritis linked with Hel...
1 min
Linaclotide vs. lactulose: Which works better for...
In a randomized controlled trial, linaclotide markedly outperformed lactulose in improving both upper and lower gastrointestinal (GI) symptoms in...
2 min
Synbiotic-enriched formula softens stools and impr...
According to the findings of a trial led by Xiaoyang Sheng et al., an organic infant formula enriched with synbiotics—specifically Bifidoba...
2 min
Study compares tegoprazan vs. PPIs for erosive eso...
A systematic review and meta-analysis has revealed that tegoprazan, a novel potassium-competitive acid blocker (P-CAB), is as effective and safe...
2 min
Impact of L. reuteri on infantile colic and parent...
Infantile colic, marked by persistent and excessive crying in otherwise healthy infants, poses a notable concern for both caregivers and medical...
1 min
Acotiamide shows encouraging results for pediatric...
A new study suggests that acotiamide, a prokinetic agent commonly used in adults, may also be beneficial in easing the symptoms of functional dys...
1 min
Rabeprazole and vonoprazan dual therapies match qu...
A retrospective study analyzing data from 300 Helicobacter pylori (H. pylori)-positive patients suggests that dual therapy regimens using rabepra...
1 min
High visceral fat score linked to greater risk of...
A large-scale population study has identified a strong link between visceral fat accumulation—measured using the Metabolic Score for Viscer...
2 min
Clinical trial reveals black raspberries’ triple b...
A new study has uncovered compelling evidence that black raspberries (BRBs) may offer a triple-action benefit for people with mild Alzheimer&rsqu...
1 min
Myo-inositol for GDM prevention: What the latest evidence reveals...
Myo-inositol substantially lowers the incidence of gestational diabetes, improves glucose tolerance, and reduces risks of preterm birth and pregn...
Long-term benefits of ligation-assisted antireflux mucosectomy in...
ARMS-L significantly alleviates GERD symptoms and enhances long-term quality of life, especially in PPI-dependent patients with cardioesophageal...
Trial supports steamed ginger extract for better digestive health
GGE03, a steamed ginger extract, effectively relieves abdominal pain, constipation, indigestion, and reflux while enhancing overall health and we...
European experts release guidelines for functional bloating and a...
Functional bloating and abdominal distension should be managed through a structured, evidence-based approach combining clinical diagnosis, target...
Tegoprazan matches PPI healing rates in erosive esophagitis
Tegoprazan redefines treatment for erosive esophagitis, delivering results on par with PPIs while drawing focus to the evaluation of its long-ter...
Real-world data raise concerns over PPI safety in infants
A new FAERS analysis raises concern over the safety of PPIs in infants, showing that drugs like lansoprazole increase the risk of adverse events...
Droplet digital PCR offers accurate prediction of H. pylori eradi...
Using droplet digital PCR to detect clarithromycin resistance in stored urease test samples serves as a dependable indicator of H. pylori therapy...
Tegoprazan vs. proton pump inhibitors: Comparative analysis of he...
Tegoprazan is associated with a reduced risk of liver injury when compared with traditional proton pump inhibitors.
Tegoprazan outperforms lansoprazole in healing erosive esophagiti...
Tegoprazan 50 mg offers rapid, consistent, and superior healing benefits in erosive esophagitis compared to lansoprazole 30 mg.
Is gastric acid testing unnecessary for most MEN1-ZES patients?
For MEN1-ZES management, symptom-driven endoscopy may provide more meaningful guidance than routine gastric acid testing, streamlining surveillan...
Comorbid GERD as a determinant of symptom burden in LPRD
GERD worsens the symptom burden in LPRD, with age, female sex, smoking, and alcohol use driving the risk of comorbidity.
Clinical and economic value of vonoprazan vs. tegoprazan for GERD
For GERD management, both vonoprazan and tegoprazan illustrate favorable overall value, with vonoprazan performing marginally better across econo...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.